Evidence map›Paper›PMID 37194091›Full record

ArticleWorld journal of surgical oncology2023

Association between macrocalcification and papillary thyroid carcinoma and corresponding valuable diagnostic tool: retrospective study.

Mengyao Ye, Shan Wu, Qi Zhou, Fang Wang, Xiaojun Chen, Xiaohua Gong, Wenjun Wu

Open access · goldAbstract read
In one paragraph

Article in World journal of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mengyao YeDepartment of Endocrinology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, Zhejiang, 325015, China.
Shan WuDepartment of Endocrinology, People's Hospital of Yuhuan, Taizhou, Zhejiang, 318000, China.
Qi ZhouDepartment of Endocrinology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325015, China.
Fang WangDepartments of Pathology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325015, China.
Xiaojun ChenDepartment of Endocrinology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325015, China.
Xiaohua GongDepartment of Endocrinology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325015, China. gxh1204@163.com.
Wenjun WuDepartment of Endocrinology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325015, China. wwju127@126.com.
First Affiliated Hospital of Wenzhou Medical University · CNWenzhou Medical University · CNYuxian People's Hospital · CN

Funding

Science and Technology Plan Project of Wenzhou, China Y20180088
6 · The paper itself

Abstract

backgroundMicrocalcifications are suggested to be an indicator of thyroid malignancy, especially for papillary thyroid carcinoma (PTC), nonetheless, the association between macrocalcification and PTC is underexplored. Furthermore, screening methods like ultrasonography and ultrasound-guided fine needle aspiration biopsy (US-FNAB) are limited in evaluating macro-calcified thyroid nodules. Thus, we aimed to investigate the relationship between macrocalcification and PTC. We also explored the diagnostic efficiency of US-FNAB and proto-Oncogene Proteins B-raf V600E (BRAF V600E) mutation in macro-calcified thyroid nodules evaluation.

methodsA retrospective research of 2645 thyroid nodules from 2078 participants was performed and divided into three groups as non-, micro-, and macro-calcified for further PTC incidence comparison. Besides, a total of 100 macro-calcified thyroid nodules with both results of US-FNAB and BRAF V600E mutation were screened out for subsequent evaluation of diagnostic efficiency.

resultsCompared to non-calcification, macrocalcification showed a significantly higher incidence of PTC (31.5% vs. 23.2%, P<0.05). Additionally, when compared with a single US-FNAB, the combination of US-FNAB and BRAF V600E mutation showed better diagnostic efficiency in diagnosing macro-calcified thyroid nodule (area under the curve (AUC) 0.94 vs. 0.84, P=0.03), with a significantly higher sensitivity (100.0% vs. 67.2%, P<0.01) and a comparable standard of specificity (88.9% vs. 100.0%, P=0.13).

conclusionsOccurrence of macrocalcification in thyroid nodules may suggest a high risk of PTC, and the combination of US-FNAB and BRAF V600E showed a greater value in identifying macro-calcified thyroid nodules, especially with significantly higher sensitivity.

trial registrationThe Ethics Committee of The First Affiliated Hospital of Wenzhou Medical University (2018-026).

Indexed as

Carcinoma, PapillaryThyroid NeoplasmsThyroid NoduleDNA Mutational AnalysisHumansMutationProto-Oncogene Proteins B-rafRetrospective StudiesThyroid Cancer, PapillaryProto-Oncogene Proteins B-rafFine needle aspiration biopsyMacrocalcificationPapillary thyroid carcinomaProto-Oncogene Proteins B-raf V600EThyroid nodule

Identifiers

PMID37194091
PMCPMC10186772
OpenAlexW4376644545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.